Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
7.22
+0.14 (1.98%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $357.42 million as of April 26, 2024. Its market cap has increased by 7.82% in one year.
Market Cap
357.42M
Enterprise Value
143.38M
1-Year Change
7.82%
Ranking
Category
Stock Price
$7.22
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $357.42M, a decrease of -10.14%. That is a compound annual growth rate of -4.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 350.50M | -0.28% |
Apr 24, 2024 | 351.50M | -1.65% |
Apr 23, 2024 | 357.40M | 1.82% |
Apr 22, 2024 | 351.00M | -1.38% |
Apr 19, 2024 | 355.90M | 1.83% |
Apr 18, 2024 | 349.50M | 0.43% |
Apr 17, 2024 | 348.00M | -3.17% |
Apr 16, 2024 | 359.40M | -3.85% |
Apr 15, 2024 | 373.80M | 0.13% |
Apr 12, 2024 | 373.30M | -2.07% |
Apr 11, 2024 | 381.20M | 1.06% |
Apr 10, 2024 | 377.20M | -2.81% |
Apr 9, 2024 | 388.10M | 7.99% |
Apr 8, 2024 | 359.40M | 0.84% |
Apr 5, 2024 | 356.40M | 0.42% |
Apr 4, 2024 | 354.90M | -1.80% |
Apr 3, 2024 | 361.40M | -1.34% |
Apr 2, 2024 | 366.30M | -4.66% |
Apr 1, 2024 | 384.20M | -1.13% |
Mar 28, 2024 | 388.60M | 1.94% |
Mar 27, 2024 | 381.20M | 30.59% |
Mar 26, 2024 | 291.90M | -3.44% |
Mar 25, 2024 | 302.30M | -6.15% |
Mar 22, 2024 | 322.10M | -1.53% |
Mar 21, 2024 | 327.10M | 2.25% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tactile Systems Technology | 357.34M |
Precigen | 353.46M |
Health Catalyst | 353.13M |
ModivCare | 352.68M |
Rani Therapeutics Holdings | 352.40M |
Aquestive Therapeutics | 350.87M |
Caribou Biosciences | 347.71M |
Mersana Therapeutics | 347.28M |